Current recommendations for procedure selection in class I and II obesity developed by an expert modified Delphi consensus.

Bariatric surgery Class I and II obesity Consensus Metabolic surgery Procedure selection

Journal

Scientific reports

ISSN: 2045-2322

Titre abrégé: Sci Rep

Pays: England

ID NLM: 101563288

Informations de publication

Date de publication:
11 Feb 2024

Historique:

received: 30 10 2023

accepted: 08 02 2024

medline: 11 2 2024

pubmed: 11 2 2024

entrez: 10 2 2024

Statut: epublish

Résumé

Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, and progressive disease. Recently, the American Society of Metabolic and Bariatric Surgery (ASMBS) and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) issued new guidelines on the indications for MBS, which have superseded the previous 1991 National Institutes of Health guidelines. The aim of this study is to establish the first set of consensus guidelines for selecting procedures in Class I and II obesity, using an Expert Modified Delphi Method. In this study, 78 experienced bariatric surgeons from 32 countries participated in a two-round Modified Delphi consensus voting process. The threshold for consensus was set at an agreement or disagreement of ≥ 70.0% among the experts. The experts reached a consensus on 54 statements. The committee of experts reached a consensus that MBS is a cost-effective treatment option for Class II obesity and for patients with Class I obesity who have not achieved significant weight loss through non-surgical methods. MBS was also considered suitable for patients with Type 2 diabetes mellitus (T2DM) and a body mass index (BMI) of 30 kg/m

Identifiants

DOI: 10.1038/s41598-024-54141-6 PMID: 38341469

pubmed: 38341469

doi: 10.1038/s41598-024-54141-6

pii: 10.1038/s41598-024-54141-6

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

3445

Informations de copyright

Références

Tucker, S. et al. The most undertreated chronic disease: Addressing obesity in primary care settings. Curr. Obes. Rep. 10(3), 396–408 (2021).

doi: 10.1007/s13679-021-00444-y pubmed: 34297343 pmcid: 8300078

Kermansaravi, M. et al. De novo inflammatory bowel disease following bariatric surgery: A systematic review and meta-analysis. Obes. Surg. 32(10), 3426–3434 (2022).

doi: 10.1007/s11695-022-06226-2 pubmed: 35906528

Bray, G. A., Kim, K. K. & Wilding, J. P. H. Obesity: A chronic relapsing progressive disease. A position statement of the World Obesity Federation. Obes. Rev. 18(7), 715–23 (2017).

doi: 10.1111/obr.12551 pubmed: 28489290

Eisenberg, D. et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes. Surg. 33(1), 3–14 (2023).

doi: 10.1007/s11695-022-06332-1 pubmed: 36336720

Gastrointestinal surgery for severe obesity. Consensus statement National Institutes of Health Consensus Development Conference. 9(1), 1-20 (1991).

Kermansaravi, M. et al. Patient selection in one anastomosis/mini gastric bypass-an expert modified delphi consensus. Obes. Surg. 32(8), 2512–2524 (2022).

doi: 10.1007/s11695-022-06124-7 pubmed: 35704259

Boyers, D. et al. Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: A decision analysis model. Int. J. Obes. 45(10), 2179–90 (2021).

doi: 10.1038/s41366-021-00849-8

Schauer, P. R. et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N. Engl. J. Med. 376(7), 641–651 (2017).

doi: 10.1056/NEJMoa1600869 pubmed: 28199805 pmcid: 5451258

Alqahtani, A. R., Elahmedi, M., Abdurabu, H. Y. & Alqahtani, S. Ten-year outcomes of children and adolescents who underwent sleeve gastrectomy: Weight loss, comorbidity resolution, adverse events, and growth velocity. J. Am. Coll. Surg. 233(6), 657–664 (2021).

doi: 10.1016/j.jamcollsurg.2021.08.678 pubmed: 34563670

Al Sabah, S. et al. Long-term outcomes of sleeve gastrectomy in adolescent patients: The effect of weight loss in younger years to outcomes in adulthood. BMC Surg. 23(1), 103 (2023).

doi: 10.1186/s12893-023-02006-6 pubmed: 37118797 pmcid: 10148482

Telem, D. A. & Ghaferi, A. A. Gastric balloons for weight loss in 2020. JAMA 324(21), 2206–2207 (2020).

doi: 10.1001/jama.2020.14862 pubmed: 33258880

Kotinda, A. et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: A systematic review and meta-analysis of randomized controlled trials. Obes. Surg. 30(7), 2743–2753 (2020).

doi: 10.1007/s11695-020-04558-5 pubmed: 32300945

Hedjoudje, A. et al. Efficacy and safety of endoscopic sleeve gastroplasty: A systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. American Gastroenterol. Assoc. 18(5), 1043–53.e4 (2020).

Shen, X., Zhang, X., Bi, J. & Yin, K. Long-term complications requiring reoperations after laparoscopic adjustable gastric banding: A systematic review. Surg. Obes. Relat. Dis. Off. J. Am. Soc. Bariatr. Surg. 11(4), 956–964 (2015).

doi: 10.1016/j.soard.2014.11.011

Angrisani, L. et al. Bariatric surgery survey 2018: Similarities and disparities among the 5 IFSO chapters. Obes. Surg. 31(5), 1937–1948 (2021).

doi: 10.1007/s11695-020-05207-7 pubmed: 33432483 pmcid: 7800839

Salminen, P. et al. Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: The sleevepass randomized clinical trial. JAMA Surg. 157(8), 656–666 (2022).

doi: 10.1001/jamasurg.2022.2229 pubmed: 35731535 pmcid: 9218929

Peterli, R. et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial. JAMA 319(3), 255–265 (2018).

doi: 10.1001/jama.2017.20897 pubmed: 29340679 pmcid: 5833546

Chiappetta, S. et al. Gastroesophageal reflux disease as an indication of revisional bariatric surgery-indication and results-a systematic review and metanalysis. Obes. Surg. 32(9), 3156–3171 (2022).

doi: 10.1007/s11695-022-06183-w pubmed: 35776239

Chiappetta, S. et al. Safety and efficacy of Roux-en-Y gastric bypass as revisional bariatric surgery after failed anti-reflux surgery: A systematic review. Surg. Obes. Relat. Dis. 19, 1317–1325 (2023).

doi: 10.1016/j.soard.2023.05.028 pubmed: 37507338

Gorodner, V. et al. Does Roux-en-Y gastric bypass really cure gastroesophageal reflux disease? Analysis of objective data. J. Laparoendosc. Adv. Surg. Tech. A 32(2), 103–110 (2022).

doi: 10.1089/lap.2020.0999 pubmed: 33844944

Schlottmann, F., Masrur, M. A., Herbella, F. A. M. & Patti, M. G. Roux-en-Y gastric bypass and gastroesophageal reflux disease: An infallible anti-reflux operation?. Obes. Surg. 32(7), 2481–2483 (2022).

doi: 10.1007/s11695-022-06083-z pubmed: 35476264

Cummings, B. P. Duodenal exclusion devices: Promising tools in treating obesity and type 2 diabetes. Gut 63(8), 1201–1202 (2014).

doi: 10.1136/gutjnl-2013-306040 pubmed: 24221455

De Luca, M. et al. Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta-analysis and network meta-analysis of randomized controlled trials. Diabetes Obes. Metab. 25(8), 2362–2373 (2023).

doi: 10.1111/dom.15117 pubmed: 37272316

Haddad, A. et al. Innovative bariatric procedures and ethics in bariatric surgery: The IFSO position statement. Obes. Surg. 32(10), 3217–3230 (2022).

doi: 10.1007/s11695-022-06220-8 pubmed: 35922610

Strain, G. W. et al. Nutrient status 9 years after biliopancreatic diversion with duodenal switch (BPD/DS): An observational study. Obes. Surg. 27(7), 1709–1718 (2017).

doi: 10.1007/s11695-017-2560-6 pubmed: 28155056

Gagner, M., Deitel, M., Erickson, A. L. & Crosby, R. D. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes. Surg. 23(12), 2013–2017 (2013).

doi: 10.1007/s11695-013-1040-x pubmed: 23912263

McGlone, E. R., Gupta, A. K., Reddy, M. & Khan, O. A. Antral resection versus antral preservation during laparoscopic sleeve gastrectomy for severe obesity: Systematic review and meta-analysis. Surg. Obes. Relat. Dis. Off. J. Am. Soc. Bariatr. Surg. 14(6), 857–864 (2018).

doi: 10.1016/j.soard.2018.02.021

Eskandaros, M. S. Antrum preservation versus antrum resection in laparoscopic sleeve gastrectomy with effects on gastric emptying, body mass index, and type II diabetes remission in diabetic patients with body mass index 30–40 kg/m(2): A randomized controlled study. Obes. Surg. 32(5), 1412–1420 (2022).

doi: 10.1007/s11695-022-05982-5 pubmed: 35304705 pmcid: 8986727

Mahawar, K. K. et al. Small bowel limb lengths and Roux-en-Y gastric bypass: A systematic review. Obes. Surg. 26(3), 660–671 (2016).

doi: 10.1007/s11695-016-2050-2 pubmed: 26749410

Parmar, C. D. et al. One anastomosis/mini gastric bypass (OAGB-MGB) as revisional bariatric surgery after failed primary adjustable gastric band (LAGB) and sleeve gastrectomy (SG): A systematic review of 1075 patients. Int. J. Surg. (Lond., Engl.) 81, 32–38 (2020).

doi: 10.1016/j.ijsu.2020.07.007

Hussain, A. et al. Retrospective cohort study of 925 OAGB procedures. The UK MGB/OAGB collaborative group. Int. J. Surg. (Lond., Engl.) 69, 13–8 (2019).

doi: 10.1016/j.ijsu.2019.07.003

Kermansaravi, M. et al. Areas of non-consensus around one anastomosis/mini gastric bypass (OAGB/MGB): A narrative review. Obes. Surg. 31(6), 2453–2463 (2021).

doi: 10.1007/s11695-021-05276-2 pubmed: 33598845

Ribeiro, R. et al. Outcomes of long pouch gastric bypass (LPGB): 4-year experience in primary and revision cases. Obes. Surg. 29(11), 3665–3671 (2019).

doi: 10.1007/s11695-019-04051-8 pubmed: 31267476

Boerboom, A. et al. An extended pouch in a Roux-En-Y gastric bypass reduces weight regain: 3-year results of a randomized controlled trial. Obes. Surg. 30(1), 3–10 (2020).

doi: 10.1007/s11695-019-04156-0 pubmed: 31444776

Sakran, N. et al. Standardization of the one-anastomosis gastric bypass procedure for morbid obesity: Technical aspects and early outcomes. Surg. Laparosc. Endosc. percutaneous Tech. 33(2), 162–170 (2023).

doi: 10.1097/SLE.0000000000001148